Form 8-K - Current report:
SEC Accession No. 0001477932-18-003269
Filing Date
2018-06-29
Accepted
2018-06-29 14:10:16
Documents
5
Period of Report
2018-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 24460
2 FORM OF WARRANT ipix_ex41.htm EX-4.1 60936
3 OPINION OF GARY R. HENRIE, ESQ. ipix_ex51.htm EX-5.1 10601
4 SECURITIES PURCHASE AGREEMENT ipix_ex101.htm EX-10.1 78368
5 PRESS RELEASE ipix_ex991.htm EX-99.1 12157
  Complete submission text file 0001477932-18-003269.txt   187892
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 18928690
SIC: 2834 Pharmaceutical Preparations